Eris Lifesciences Plans Board Meeting to Review Standalone and Consolidated Financial Results for Quarter Ended June 30, 2026
Eris Lifesciences Limited has scheduled a meeting of its Board of Directors to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The meeting is set for Wednesday, July 29, 2026.The company confirmed that the trading window was closed starting from July 01, 2026. This closure will remain in effect until 48 hours following the declaration of the financial results.
ERIS Stock Price Movement
Shares of Eris Lifesciences Limited are slipping by 1.62% in live trading as of 12:38 PM, currently priced at ₹1417.2. The stock has seen a total traded volume of 39,257 shares so far during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.